CheckMate 067: Nivolumab + Ipilimumab and Nivolumab Alone Superior to Ipilimumab Alone in Previously Untreated Advanced Melanoma

May 29-June 2, 2015; Chicago, Illinois
Data from this large phase III trial suggest that the combination of nivolumab + ipilimumab offers better efficacy vs ipilimumab alone, but also better efficacy vs nivolumab alone, particularly for patients whose tumors are low in PD-L1 expression.
Format: Microsoft PowerPoint (.ppt)
File Size: 775 KB
Released: June 2, 2015

Acknowledgements

Educational grant provided by:
AstraZeneca
Bayer Healthcare Pharmaceuticals, Inc.
Bristol-Myers Squibb
Celgene Corporation
Genentech BioOncology
Incyte
Novartis Pharmaceuticals Corporation

Related Content

In this slideset from Clinical Care Options, M. Dror Michaelson, MD, PhD and Robert Motzer, MD highlight key data on the optimal use of immune checkpoint inhibitors for RCC

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: June 26, 2020

Summary slideset for nurses and pharmacists caring for patients receiving immune checkpoint inhibitors, from CCO.

Stephanie Andrews, MS, ANP-BC Marianne Davies, DNP, CNS, ACNP-BC, AOCNP John Thompson Headshot John A. Thompson, MD Released: June 26, 2020

On-demand CCO Webcast on checkpoint inhibitors for nurses and pharmacists: educating patients, identifying and managing irAEs, adapting to COVID-19.

John Thompson Headshot John A. Thompson, MD
Program Director
Stephanie Andrews, MS, ANP-BC Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 25, 2020 Expired: June 24, 2021

In this slideset from Clinical Care Options, experts provide insights into the optimal management of toxicities associated with CAR T-cell therapy.

Noopur Raje, MD Released: June 23, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?